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Robert Koch (1843-1910) the eminent German scien- 
tist, is best known as the person who identified the 
tubercle bacillus, thereby moving tuberculosis from the 
realm of fate and character, into the bright glare of sci- 
ence. Winner of the Nobel Prize in 1905, Koch also made 
significant contributions to the understanding of cholera, 
anthrax, malaria, and the plague. 
Less well known, and certainly less celebrated, was 
Koch’s development of tuberculin, the direct antecedent 
of the preparation currently used in routine skin testing. 
But rather than envisioning tuberculin as a useful means 
of diagnosis, Koch foresaw his product as nothing less 
than the cure for tuberculosis-a disease that, at the time, 
was responsible for the death of some 25% of the adult 
population of Western Europe. 
The rise and fall of tuberculin as a therapeutic was 
startlingly rapid, with the Lancet serving as the source of 
minute-to-minute information for English readers. After 
identifying Mycobacterium tuberculosis in 1882, Koch 
spent much of the next several years working secretly 
on his treatment for tuberculosis.l In an address at the 
Tenth International Medical Congress, held in Berlin on 
August 4, 1890, Koch mentioned that he had “found a 
substance by means of which the tubercle bacillus can 
be rendered inert.“2 
Such a strong claim regarding such a prevalent and 
devastating disease was all the more sensational coming 
from a researcher with the stature and famous caution of 
Koch. In addition, Koch, allowed the drama to build, pub- 
lishing neither the composition of the magic fluid nor 
results of his trials, until tremendous pressure from the 
medical community forced his hand.3 The editors of 
Lancet, aware that disclosure of the composition would 
inevitably lead others to “try to make spurious imita- 
tions, “j still felt that the medical community must know. 
News of a possible cure, after all, had “led to the gath- 
ering in the German capital of many sufferers who had 
far better have remained at their health resorts until the 
remedy had been further tested.“3 An additional concern 
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of the British medical weekly was “the [rumoured] inten- 
tion of the German Government to retain, as it were, the 
monopoly of the remedy in its own hands.“3 
In the same November 22, 1890, issue of Lance& 
some of Koch’s preliminary results were described.4 Sub- 
cutaneous infrascapular injections were given every 1 to 
2 weeks; duration of therapy depended upon response: 
when “a tuberculous subject treated with increasing 
doses [has] no more reaction than in the non-tubercu- 
lous, then it may be inferred that there is no more tuber- 
culous tissue to be destroyed.“* Koch’s claims were bold, 
“even cases with moderately sized cavities are markedly 
improved and nearly cured.“* Koch even described a “sil- 
ver bullet” like effect: “[tuberculin] can only affect living 
tuberculous tissue.“4 Even so, Koch “urgently protested 
against the indiscriminate application of the remedy in all 
cases of tuberculosis.“” 
Despite, or because of, these forceful claims, a back- 
lash against Koch began, which the editors of the Jour- 
nal of the American MedicalAssociation warned against. 
“We notice now and then a spirit of carping criticism... 
and a disposition to belabor the eminent investigator for 
not immediately unbosoming himself [of clinical results 
and the composition of tuberculin].“5 Joseph Lister felt 
compelled to defend Koch in a public speech in Decem- 
ber 1890.6 He reminded his audience of Koch’s contri- 
butions, while attesting to the miracles of tuberculin, for 
he had just returned from a tour of Koch’s clinic, where 
he had been an invited guest. 
The criticisms, however, continued on at least three 
fronts: (1) Koch’s hesitancy to report the composition 
and means of preparation of the fluid; (2) the hint that 
the government would patent the product and become 
rich; (3) and the lack of safety and efficacy information. 
The rancour was certainly further fueled by professional 
jealousy. Lancet reported that, thankfully, the Prussian 
government had made it clear they would not make 
money from preparation of the fluid.’ However, they also 
noted that the Vienna Board of Health had outlawed injec- 
tions of Koch’s fluid, and concluded yet another editor- 
ial by stating that “the highly dangerous nature of the 
remedy must necessitate the greatest caution in its 
employment.“’ 
Finally, in January of 1891, Koch published a sketchy 
description of the fluid.8 The vagueness of the report 
only served to draw even more criticism against Koch. 
Bristowe, in the British Medical Journal, claimed that 
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“the general symptoms caused by the introduction of 
Koch’s fluid have a close resemblance to those due to 
the influence of septic poison.“9 He noted that “in the 
early days many persons.. lost their heads” due to “an 
unreasoning faith in Koch’s infallibilityY9 
The rapid fall from grace was further hastened by 
the publication, later that year, of results of therapy in 28 
patients.‘O Of these, “15 improved; 1 remained stationary; 
and 12 grew worse, of whom 3 died,” while cavities 
extended in 10 of 11. The editors summarize: “The gen- 
eral conclusion from the facts above was inevitable, 
namely that tuberculin did not in the majority of cases 
influence the course of the disease favourably.” Although 
Koch continued to study tuberculin for years, public and 
professional confidence was lost, and hope ended for 
tuberculin as a therapy for the disease. 
From this large and dramatic failure, however, 
emerged the current role for tuberculin: as a diagnostic 
test for latent infection. Early on, Koch and others noted 
that uninfected persons demonstrated no reaction to the 
injection, whereas those with tuberculosis developed “a 
feverish attack, characterized usually by pains in the 
limbs, shivering prostration, nausea, and perhaps vomit- 
ing.“6 This phenomenon led Koch to suggest that “the 
injection may become a valuable aid in the diagnosis of 
obscure cases of the disease and of commencing phthi- 
sis,“* a feeling held by others-“There is a general con- 
sensus of opinion that the remedy has a specific effect 
upon tubercular tissues, and is therefore applicable as a 
very delicate and sure agent for the discovery of latent 
and doubtful tuberculous processes.“s 
According to many, Sir Arthur Conan Doyle was the 
first to suggest the broad use of the tuberculin skin test 
to identify latently infected persons in populations,” 
although the utility was noted earlier by veterinarians, 
for whom Mycobacterium bovis was a major scourge.” 
Despite the contributions of the test to global tuber- 
culosis control efforts, the well-known idiosyncrasies of 
the tuberculin skin test also were noted early. Bristowe, 
in his 1891 vitriolic against Koch, noted about the fluid: 
“the local reaction is very uncertain,“’ describing with 
perfect clarity all that was unclear about tuberculin skin 
test interpretation in 1891, and for the hundred-plus ensu- 
ing years. 
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